Liquid Biopsy in Ewing Sarcoma and Osteosarcoma As a Prognostic and Response Diagnostic: LEOPARD

NARecruitingINTERVENTIONAL
Enrollment

340

Participants

Timeline

Start Date

May 8, 2018

Primary Completion Date

January 1, 2026

Study Completion Date

January 1, 2026

Conditions
Ewing SarcomaEwing Sarcoma of BoneEwing Sarcoma of Soft TissuePeripheral Primitive Neuroectodermal TumorPeripheral Primitive Neuroectodermal Tumor of BonePeripheral Primitive Neuroectodermal Tumor of Soft TissueHigh-grade Osteosarcoma
Interventions
OTHER

FoundationOne Liquid CDx

a FoundationOne liquid biopsy test kit will be sent to the laboratory of the subject's treating center, in addition to the paired cell stabilizing tube from the primary center

Trial Locations (15)

19104

RECRUITING

Children's Hospital of Philadelphia, Philadelphia

30322

RECRUITING

Children's Healthcare of Atlanta, Atlanta

38105

RECRUITING

St. Jude Children's Research Hospital, Memphis

43205

RECRUITING

Nationwide Children's Hospital, Columbus

55404

RECRUITING

Children's Hospital's and Clinics of Minnesota, Minneapolis

75390

RECRUITING

UT Southwestern Medical Center, Dallas

84113

RECRUITING

University of Utah Childrens Medical Center, Salt Lake City

98105

RECRUITING

Seattle Children's Hospital, Seattle

90027-0700

RECRUITING

Childrens Hospital Los Angeles, Los Angeles

02114

RECRUITING

Massachusetts General Hospital Cancer Center, Boston

02115

RECRUITING

Boston Children's Hospital, Boston

RECRUITING

Brigham and Women's Hospital, Boston

RECRUITING

Dana Farber Cancer Institute, Boston

45229-3039

RECRUITING

Cincinnati Children's Hospital Medical Center, Cincinnati

02903

RECRUITING

Lifespan / Rhode Island Hospital, Providence

All Listed Sponsors
collaborator

Alex's Lemonade Stand Foundation

INDUSTRY

collaborator

Conquer Cancer Foundation

OTHER

collaborator

Harvard University

OTHER

collaborator

Sam Day Foundation

UNKNOWN

lead

Dana-Farber Cancer Institute

OTHER